iRhythm Holdings (IRTC) Cash & Current Investments (2015 - 2026)
iRhythm Holdings' (IRTC) quarterly Cash & Current Investments came in at $549.6 million in Q1 2026, up 5.58% year-on-year from $520.6 million in Q1 2025, and down 5.85% on a QoQ basis from $583.8 million in Q4 2025.
iRhythm Holdings (IRTC) Cash & Current Investments (2015 - 2026) Analysis & Trends
iRhythm Holdings (IRTC) has 12 years of Cash & Current Investments data on file, last reported at $549.6 million in Q1 2026.
- On a quarterly basis, Cash & Current Investments rose 5.58% year-over-year to $549.6 million in Q1 2026; TTM through Mar 2026 was $549.6 million, a 5.58% increase from a year earlier, with the FY2025 full-year figure at $583.8 million, up 9.0% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $549.6 million, down from $583.8 million in the prior quarter.
- Over the last five years, Cash & Current Investments for IRTC reached as high as $583.8 million in Q4 2025 and fell as low as $133.8 million in Q4 2023.
- Historically, Cash & Current Investments has averaged $363.3 million across 5 years, with a median of $450.9 million in 2025.
- Across the five-year window, Cash & Current Investments slumped 40.3% in 2022 and jumped 300.37% in 2024, its largest moves.
- Year by year, Cash & Current Investments stood at $213.1 million in 2022, then sank by 37.24% to $133.8 million in 2023, then soared by 300.37% to $535.6 million in 2024, then rose by 9.0% to $583.8 million in 2025, then dropped by 5.85% to $549.6 million in 2026.
- Per Business Quant data, the three most recent Cash & Current Investments figures were $549.6 million in Q1 2026, $583.8 million in Q4 2025, and $472.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 1.12 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 2.29 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 577.00 Mn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 3.12 Bn |
| 10 | iRhythm Holdings | 3.65 Bn | 3.10 Bn | 141.35 Mn | 549.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 549.62 Mn |
| Dec 31, 2025 | 583.76 Mn |
| Sep 30, 2025 | 472.07 Mn |
| Jun 30, 2025 | 450.88 Mn |
| Mar 31, 2025 | 520.59 Mn |
| Dec 31, 2024 | 535.55 Mn |
| Sep 30, 2024 | 522.03 Mn |
| Jun 30, 2024 | 561.46 Mn |
| Mar 31, 2024 | 569.09 Mn |
| Dec 31, 2023 | 133.76 Mn |
| Sep 30, 2023 | 158.47 Mn |
| Jun 30, 2023 | 164.74 Mn |
| Mar 31, 2023 | 176.34 Mn |
| Dec 31, 2022 | 213.14 Mn |
| Sep 30, 2022 | 203.54 Mn |
| Jun 30, 2022 | 204.49 Mn |
| Mar 31, 2022 | 156.59 Mn |
| Dec 31, 2021 | 221.71 Mn |
| Sep 30, 2021 | 221.80 Mn |
| Jun 30, 2021 | 221.41 Mn |